OncoHost is a commercial-stage precision oncology company headquartered in Binyamina, Israel, and Cary, NC. Led by an experienced team of entrepreneurs and industry experts, and supported by a large-scale prospective clinical trial with over 35 sites worldwide, OncoHost aims to understand the patient's unique response to cancer therapy to overcome one of the major obstacles in clinical oncology today – resistance to treatment.
Supported by robust clinical evidence, strong IP positioning, and first-mover advantage, OncoHost has developed the PROphet® platform to guide earlier and more informed decision-making in the planning and management of individual patients' therapeutic journeys.
Supported by robust clinical evidence, strong IP positioning, and first-mover advantage, OncoHost has developed the PROphet® platform to guide earlier and more informed decision-making in the planning and management of individual patients' therapeutic journeys.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Israel
Year Founded:
2017
Main Therapeutic Focus:
Oncology
Lead Product in Development:
PROphet
Development Phase of Primary Product:
Other/Not Applicable
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
